Safety and Efficacy of Therapeutic Cancer Vaccines Alone or in Combination With Immune Checkpoint Inhibitors in Cancer Treatment
Therapeutic cancer vaccines have proven to seldom induce dramatic clinical response when used alone, and therefore, they are being studied in combination with additional treatment modalities to achieve optimal treatment activities. Growing preclinical data show that combining vaccines and immune che...
Saved in:
Main Authors: | Jing Zhao (Author), Ye Chen (Author), Zhen-Yu Ding (Author), Ji-Yan Liu (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2019-10-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Immune Checkpoint Inhibitor-Associated Cardiotoxicity: Current Understanding on Its Mechanism, Diagnosis and Management
by: Yu-Wen Zhou, et al.
Published: (2019) -
PD-1 Inhibitors in the Advanced Esophageal Cancer
by: Ye Hong, et al.
Published: (2019) -
The safety concerns regarding immune checkpoint inhibitors in liver cancer patients rising mainly from CHB
by: Shike Lou, et al.
Published: (2023) -
Application of immune checkpoint inhibitors for resectable gastric/gastroesophageal cancer
by: Feizhi Lin, et al.
Published: (2024) -
Resistance to immune checkpoint inhibitors in gastric cancer
by: Kai Liu, et al.
Published: (2023)